VERASTEM ONCOLOGY
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.
VERASTEM ONCOLOGY
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2010-01-01
Address:
Needham, Massachusetts, United States
Country:
United States
Website Url:
http://www.verastem.com
Total Employee:
101+
Status:
Active
Contact:
1-781-292-4200
Email Addresses:
[email protected]
Total Funding:
379.1 M USD
Technology used in webpage:
Amazon Mobile Non Scaleable Content HSTS IPv6 CrUX Top 50m Amazon Virginia Region Microsoft CloudFront Ruby On Rails Token New Relic
Similar Organizations
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Verastem Oncology
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Verastem Oncology
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Verastem Oncology
Bessemer Venture Partners
Bessemer Venture Partners investment in Series C - Verastem Oncology
MPM Capital
MPM Capital investment in Series C - Verastem Oncology
Longwood Fund
Longwood Fund investment in Series C - Verastem Oncology
Cardinal Partners
Cardinal Partners investment in Series C - Verastem Oncology
Astellas Venture Management
Astellas Venture Management investment in Series B - Verastem Oncology
Bessemer Venture Partners
Bessemer Venture Partners investment in Series B - Verastem Oncology
MPM Capital
MPM Capital investment in Series B - Verastem Oncology
Key Employee Changes
| Date | New article |
|---|---|
| 2023-10-26 | Verastem Oncology appoints Dan Calkins as CFO |
| 2023-07-11 | Verastem Oncology promotes Dan Paterson to CEO role |
| 2021-09-22 | Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.verastem.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.25 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Verastem Oncology"
Verastem Oncology - Wikipedia
Verastem Oncology (Verastem Inc) was co-founded in 2010 by entrepreneur Christoph H. Westphal and venture capitalist Michelle Dipp, who provided seed funding and initial office space in Cambridge, MA. The company was formed to commercialize the work of the three other co-founders, MIT biologists Robert F. Weinberg, Eric S. Lander and Piyush Gupta, by discovering and developing drugs to treat cancer by targeting cancer stem cells. See details»
Our Leadership - Verastem Oncology
Cathy Carew, Chief Organizational Effectiveness Officer. Ms Carew has been with Verastem …See details»
Verastem Oncology - Crunchbase Company Profile
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of …See details»
Verastem - Org Chart, Teams, Culture & Jobs - The Org
View Verastem's up-to-date org chart, open roles, and culture details. Find executives, board …See details»
Verastem Oncology - LinkedIn
Chief Organization Effectiveness Officer at Verastem Oncology Steve Engen CEO, Renexes …See details»
Verastem Oncology Announces Executive Leadership …
Source: Verastem, Inc. Verastem Oncology: Brian Sullivan, +1 781-469-1636 Senior Director, …See details»
Verastem Oncology - Funding, Financials, Valuation & Investors
Verastem Oncology is registered under the ticker NASDAQ:VSTM . Their stock opened with …See details»
Verastem, Inc. (LON: 0LOV) Company Profile & Overview - Stock …
Dec 31, 2024 Verastem, Inc., a development-stage biopharmaceutical company, focuses on …See details»
Julie Feder | Management - Verastem, Inc.
Ms. Feder joins Verastem from the Clinton Health Access Initiative, Inc. (CHAI), where she …See details»
Verastem Oncology - Contacts, Employees, Board Members
Organization. Verastem Oncology . Connect to CRM . Save . Summary. Financials. People. …See details»
Verastem, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Verastem, Inc. with its drug pipeline, therapeutic area, technology platform, 46 clinical …See details»
Verastem - Overview, News & Similar companies | ZoomInfo.com
Mar 18, 2024 Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial …See details»
Michelle Robertson - Verastem, Inc.
Ms Robertson is the Executive Vice President and Chief Financial Officer of Geron …See details»
Verastem Shares Surge Over 24% on FDA Acceptance of Cancer …
Dec 31, 2024 Verastem's president and CEO, Dan Paterson, hailed the FDA's approval as a …See details»
About Verastem | Verastem Oncology
Verastem Oncology is not responsible for the content of linked third party websites. We are not …See details»
Verastem's SWOT analysis: biotech firm's stock rides on …
1 day ago Verastem Inc (NASDAQ: VSTM), a biopharmaceutical company with a market …See details»
Investor Information | VSTM Stock | Verastem Oncology
Verastem is a member of NASDAQ Biotechnology Index. For additional information, please …See details»
Verastem Oncology Announces FDA Acceptance and Priority …
Dec 30, 2024 This press release includes forward-looking statements about, among other …See details»
Our Culture | About Us | Verastem Oncology
Get to Know Our Team. Meet Faye. Faye is Verastem Oncology’s Head of Chemistry, …See details»
Corporate Presentation - Verastem Oncology
Verastem Oncology’s product candidates, that are subject to substantial risks and uncertainties …See details»